- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04781738
Functional Capacity and Quality of Life in Patients With Vascular Ring
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Vascular rings are congenital vascular anomalies of the aortic arch that compress the esophagus and the trachea. The most common vascular rings are double aortic arch and right aortic arch with left ligamentum. Pulmonary artery sling is less common. Another cause of tracheal compression occurring only in infants is the innominate artery compression syndrome. When patients are symptomatic, surgical correction should be performed.
data regarding long term functional capacity and quality of life is lacking. our aim is to investigate the long term functional capacity and quality of life of patients with history of vascular ring whether they did or did not have corrective surgery.
Methods: a prospective study evaluating functional capacity and quality of life the patients will perform pulmonary function test, 6 minute walk test, cardiopulmonary exercise test and will fill a quality of life questionnaire (sf-36).
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Lea Bentur, MD
- Phone Number: +972-4-7774360
- Email: l_bentur@rambam.health.gov.il
Study Contact Backup
- Name: Vered Nir, MD
- Phone Number: +972-4-7774360
- Email: v_nir@rambam.health.gov.il
Study Locations
-
-
-
Haifa, Israel
- Recruiting
- Rambam Health Care Campus
-
Contact:
- Lea Bentur, Prof.
- Phone Number: 972-4-777-4360
- Email: l_bentur@rambam.health.gov.il
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with history of vascular ring
Exclusion Criteria:
- refusal to participate
- inability to complete cardiopulmonary testing
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patients with history of vascular ring who didn't have corrective surgery
|
CPET using a cycle ergometer (COSMED, Rome, Italy) beginning with no resistance warmup lasting 1-3 minutes followed with an incrementing resistance adapted to the patient's functional capacities according to the examiner's free judgment by successive stages Six minute walk test - patients will be instructed to walk as far as possible for six minutes in a 30-meter long enclosed corridor with a flat and hard surface, marked at every meter. Meters will be calculated at the end of the test. SF-36 is a questionnaire that contains eight domains - physical functioning (10 items); role limitations due to physical functioning (4 items); role limitations due to emotional problems (3 items); energy and vitality (4 items); mental health (5 items); social functioning (2 items); bodily pain (2 items); and general health perceptions (5 items). Scores are summed for each domain and were transformed into scores of between 0 (worst possible health state) to 100 (best possible health state).
Other Names:
|
patients with history of vascular ring who underwent corrective surgery
|
CPET using a cycle ergometer (COSMED, Rome, Italy) beginning with no resistance warmup lasting 1-3 minutes followed with an incrementing resistance adapted to the patient's functional capacities according to the examiner's free judgment by successive stages Six minute walk test - patients will be instructed to walk as far as possible for six minutes in a 30-meter long enclosed corridor with a flat and hard surface, marked at every meter. Meters will be calculated at the end of the test. SF-36 is a questionnaire that contains eight domains - physical functioning (10 items); role limitations due to physical functioning (4 items); role limitations due to emotional problems (3 items); energy and vitality (4 items); mental health (5 items); social functioning (2 items); bodily pain (2 items); and general health perceptions (5 items). Scores are summed for each domain and were transformed into scores of between 0 (worst possible health state) to 100 (best possible health state).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise capacity
Time Frame: Measured continuously during 15 minutes of the exercise test (CPET)
|
Oxygen uptake evaluated by cardiopulmonary exercise testing (CPET)
|
Measured continuously during 15 minutes of the exercise test (CPET)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Six minute walk test
Time Frame: Six minutes of evaluation, completed pre cardiopulmonary exercise test (CPET)
|
The distance gained after six minute of habitual walking.
|
Six minutes of evaluation, completed pre cardiopulmonary exercise test (CPET)
|
Quality of life - SF-36
Time Frame: Five minutes of evaluation, completed pre cardiopulmonary exercise test (CPET)
|
The calculated result of SF-36 questionnaire
|
Five minutes of evaluation, completed pre cardiopulmonary exercise test (CPET)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lea Bentur, MD, Head of Pediatric Pulmonary Institute
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RMB-0218-17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Ring
-
Dongyang People's HospitalRecruiting
-
Centre Hospitalier Universitaire de NiceCompletedPelvic Ring Tumor LesionsFrance
-
Medical University of ViennaUnknownIntraocular Lens Rotation | Capsular Tension RingAustria
-
Organon and CoCompletedContraception: Optional Applicator for Insertion of Vaginal Ring
-
Duke UniversityWake Forest University Health Sciences; Orthopaedic Trauma Association; Prisma...Completed
-
Cairo UniversityNot yet recruiting
-
Zhejiang Cancer HospitalActive, not recruitingGastric Cancer | Signet Ring Cell CarcinomaChina
-
Indiana UniversityTerminatedAnterior Pelvic Ring FracturesUnited States
-
Ophthalmic Consultants of BostonCompletedPosterior Vitreous Detachment | Weiss Ring | Floaters
-
ElsanActive, not recruitingKeratoconus | Laser | Intracorneal RingFrance
Clinical Trials on Cardiopulmonary exercise test
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingFabry Disease | Fabry Disease, Cardiac VariantNetherlands
-
University of HullSheffield Hallam UniversityTerminated
-
Virginia Commonwealth UniversityNovartis PharmaceuticalsCompletedPrior Acute Myocardial Infarction | Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l) | Reduced Left Ventricle Ejection Fraction (<50%) | Symptoms of Heart Failure (NYHA Class II-III)United States
-
Hasselt UniversityCompletedCoronary Artery Bypass SurgeryBelgium
-
The Clatterbridge Cancer Centre NHS Foundation...University of Liverpool Cancer Research CentreNot yet recruiting
-
Bezmialem Vakif UniversityCompleted
-
Chang Gung Memorial HospitalCompletedComorbid Chronic Lung Disease on Heart Failure
-
Imperial College LondonCompletedHereditary Hemorrhagic Telangiectasia | Pulmonary Arteriovenous MalformationsUnited Kingdom
-
Wissenschaftliches Institut Bethanien e.VRoche Pharma AGCompleted
-
Massachusetts General HospitalCompletedInsulin Resistance | Overweight and ObesityUnited States